The U.S. Military HIV Research Program (MHRP) was established in 1985 to protect U.S. troops entering endemic HIV areas and is dedicated to HIV vaccine development, prevention, disease surveillance, and HIV care and treatment. NIAID plans and executes HIV/AIDS research projects annually with MHRP through an interagency agreement on HIV vaccine research.
Main Areas of Focus
- To protect the U.S. Military from HIV
- To improve global health by conducting research to develop an HIV vaccine, reduce new infections and find a cure
Oversight
The Walter Reed Army Institute of Research (WRAIR) at the US Military Research and Materiel Command (MRMC) and the Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID) have agreed to coordinate their efforts to maximize each agency's resources, fulfill their respective missions, and streamline the operational and scientific aspects of clinical trials. Both agencies stress the importance of robust oversight of the jointly developed Interagency Agreement (IAA) through coordinated planning and systematic review of the Military HIV Research Program’s (MHRP) HIV/AIDS research initiatives. A detailed, multi-year research plan, created following the MRDC guidelines, undergoes annual programmatic and resource evaluations by the Military Infectious Diseases Research Program (MIDRP) to ensure it aligns with the missions of both agencies. Oversight is further strengthened by external peer reviews of project proposals and progress reports, with DAIDS staff assessing scientific merit and relevance to their research priorities. DAIDS and MIDRP jointly manage funding decisions.
Read more about this network: U.S. Military HIV Research Program (MHRP)
Locations
MHRP Headquarters
6720A Rockledge Drive Suite 400
Bethesda, MD 20817
There are multiple MHRP locations both domestic and abroad.